Estrella Immunopharma (ESLA) Other Accumulated Expenses (2023 - 2026)
Estrella Immunopharma (ESLA) posted quarterly Other Accumulated Expenses of $1587.0 for Q1 2026, down 50.41% year-over-year from $3200.0 in Q1 2025, and down 91.54% quarter-over-quarter from $18751.0 in Q4 2025.
Estrella Immunopharma (ESLA) Other Accumulated Expenses (2023 - 2026) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Other Accumulated Expenses for 4 consecutive years, with $1587.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 50.41% year-over-year to $1587.0; the TTM figure through Mar 2026 stood at $1587.0 (down 50.41% YoY), while the FY2025 annual figure was $18751.0, up 76.38% from the prior year.
- Other Accumulated Expenses declined to $1587.0 in Q1 2026 per ESLA's latest filing, from $18751.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $24000.0 in Q3 2023 and bottomed at $347.0 in Q2 2024.
- Historically, Other Accumulated Expenses has averaged $8629.0 across 4 years, with a median of $3012.5 in 2024.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses plunged 98.42% — and 2025, when it surged 718.41%.
- Estrella Immunopharma's Other Accumulated Expenses stood at $2558.0 in 2023, then surged by 315.6% to $10631.0 in 2024, then soared by 76.38% to $18751.0 in 2025, then sank by 91.54% to $1587.0 in 2026.
- Business Quant data shows ESLA's Other Accumulated Expenses at $1587.0 in Q1 2026, $18751.0 in Q4 2025, and $3200.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,059.00 |
| Mar 31, 2026 | 1,587.00 |
| Dec 31, 2025 | 18,751.00 |
| Mar 31, 2025 | 3,200.00 |
| Dec 31, 2024 | 10,631.00 |
| Sep 30, 2024 | 2,825.00 |
| Jun 30, 2024 | 347.00 |
| Mar 31, 2024 | 391.00 |
| Dec 31, 2023 | 2,558.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 22,000.00 |